• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Catalog Number UNK AMPLATZER SEPTAL OCCLUDER
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/01/2007
Event Type  Injury  
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.Literature attachment: transcatheter closure of secundum atrial septal defects in pediatric patients: a 15-year single- center experience.The udi number is not known as the part and lot number were not provided.
 
Event Description
The article, "transcatheter closure of secundum atrial septal defects in pediatric patients: a 15-year single- center experience", was reviewed.The article presented a retrospective, single center study on the center's experience with transcatheter closure of atrial septal defects (asds) over the last 15 years.Devices included amplatzer septal occluder, occlutech figulla asd occluder, lifetech ceraflex, and solysafe septal occluder.The article concluded that with appropriate patient and device selection, transcatheter closure is a safe and effective treatment for secundum asd and should be the first treatment of choice.[the primary and corresponding author was eser dogan, department of pediatric cardiology, faculty of medicine, ege university, izmir, turkey, with corresponding email: eserdogan86@hotmail.Com].The time frame of the study was from january 2007 to january 2023.A total of 323 patients were included in this study, of which 277 (85.8%) received an abbott device.The average age was 8.08 years and the majority gender was female.Comorbidities included atrial septal defect (asd) including single or multiple secundum asds.
 
Manufacturer Narrative
Summarized patient outcomes/complications of transcatheter closure of secundum atrial septal defects in pediatric patients: a 15-year single- center experience were reported in a research article in a subject population with multiple co-morbidities including atrial septal defect (asd) including single or multiple secundum asds.Some of the complications reported were device embolization, surgical intervention these complications are anticipated for the procedure and subject population.A more comprehensive assessment could not be performed as the event was non-contemporaneously reported through a literature review and no device or individual patient information was received for analysis.Literature article title: transcatheter closure of secundum atrial septal defects in pediatric patients: a 15-year single- center experience.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER SEPTAL OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT MEDICAL REG# 2135147
5050 nathan ln n
plymouth MN 55442
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key19163644
MDR Text Key340838389
Report Number2135147-2024-01805
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeTU
PMA/PMN Number
P000039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/16/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK AMPLATZER SEPTAL OCCLUDER
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/29/2024
Initial Date FDA Received04/23/2024
Supplement Dates Manufacturer Received04/23/2024
Supplement Dates FDA Received05/16/2024
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-